Results 41 to 50 of about 385,713 (293)

Wearable Sensors for Vital Signs Measurement: A Survey

Journal of Sensor and Actuator Networks, 2022
With the outbreak of coronavirus disease-2019 (COVID-19) worldwide, developments in the medical field have aroused concerns within society. As science and technology develop, wearable medical sensors have become the main means of medical data acquisition.
Zhihan Lv, Yuxi Li
doaj   +1 more source

Gut microbiome and aging—A dynamic interplay of microbes, metabolites, and the immune system

FEBS Letters, EarlyView.
Age‐dependent shifts in microbial communities engender shifts in microbial metabolite profiles. These in turn drive shifts in barrier surface permeability of the gut and brain and induce immune activation. When paired with preexisting age‐related chronic inflammation this increases the risk of neuroinflammation and neurodegenerative diseases.
Aaron Mehl, Eran Blacher
wiley   +1 more source

Revising Vital Signs Criteria for Accurate Triage of Older Adults in the Emergency Department

, 2022
Yi-Chia Su,1,2 Cheng-Yu Chien,1– 5 Chung-Hsien Chaou,1,2 Kuang-Hung Hsu,1,2,6,7 Shi-Ying Gao,1 Chip-Jin Ng1,2 1Department of Emergency Medicine, Chang Gung Memorial Hospital, Taoyuan, Taiwan; 2College of Medicine, Chang Gung University, Taoyuan, Taiwan ...
Gao SY, Hsu KH, Ng CJ, Chien CY, Chaou CH, Su YC   +5 more
core  

Lessons Learned from Implementing a Rapid Test of a Technology Device in a Tertiary Hospital in Uganda

Annals of Global Health, 2016
Background: Many African hospitals participate in technology research studies that take many months or years. Fewer sites have experience with rapid studies, conducted over a period of weeks.
Pauline Byakika-Kibwika, Moses Muwonge, William Watts, Justine Kange, Raleigh Watts   +4 more
doaj   +1 more source

Human Vital Signs Detection: A Concurrent Detection Approach

Applied Sciences, 2022
The measurement of heartbeat rate and breathing rate for patients with sensitive skin, such as skin with burns, is very difficult to do, especially if the number of patients is large and medical personnel is limited.
Tjahjo Adiprabowo, Ding-Bing Lin, Tse-Hsuan Wang, Ariana Tulus Purnomo, Aloysius Adya Pramudita   +4 more
doaj   +1 more source

Keratin 19 as a prognostic marker and contributing factor of metastasis and chemoresistance in high‐grade serous ovarian cancer

Molecular Oncology, EarlyView.
Keratin 19 (KRT19) is overexpressed in high‐grade serous ovarian cancer with high levels of Kallikrein‐related peptidases (KLK) 4–7 and is associated with poor survival. In vivo analyses demonstrate that elevated KRT19 increases peritoneal tumour burden.
Sophia Bielesch, Isabel Vogel, Sina Nokodian, Johanna Moeller, Antonia Blechschmidt, Vicky Hecht, Vanessa Kuentzel, Katharina Thiedig, Melissa Schwab, Oliver Schilling, Holger Bronger, Marion Kiechle, Viktor Magdolen, Tobias Dreyer   +13 more
wiley   +1 more source

Vital signs.

, 2019
Vital signs.
Hiroyuki Hayashi (153400), Yohei Kamikawa (6281975)   +1 more
core   +1 more source

Short-Term Changes in Depressive Symptoms Among Patients with Alzheimer’s Disease Following a Precision Medicine Intervention

Brain Sciences
Background/Objectives: The ReCODE (Reversal of Cognitive Decline) protocol, a precision medicine program for patients with Alzheimer’s disease (AD), has demonstrated promising results in improving cognitive function.
Rammohan V. Rao, Alan Boyd, Sho Okada, William Lipa, Lance Kelly, Christine Coward, Aida L. Bredesen, Julie Gregory, Dale E. Bredesen   +8 more
doaj   +1 more source

Oncogenic DMTF1β promotes cancer cell motility by regulating autophagy through ULK1 stabilization

Molecular Oncology, EarlyView.
In the current study, we demonstrate that the oncogene DMTF1β regulates ULK1 stability by reducing its proteasomal degradation in cancer cells. This stabilization enables ULK1 to induce autophagy, which in turn facilitates cancer cell migration. Consequently, reduced DMTF1β levels lead to decreased autophagy and impaired cancer cell migration.
Jun Xu, Nicolas J. Niklaus, Anna M. Schläfli, Igor Tokarchuk, Magali Humbert, Federico La Manna, Bich Vu, David Maul, Ramin Radpour, Marianna Kruithof‐de Julio, Inti Zlobec, Jörn Dengjel, Bruce E. Torbett, Mario P. Tschan   +13 more
wiley   +1 more source

Patient therapy outcome modeling in cancer organoids is improved by cancer‐associated fibroblasts and organoid assembly convolution

Molecular Oncology, EarlyView.
Patient‐derived organoids (PDOs) from pancreatic, colorectal, and gastric cancers were used to evaluate standard and experimental therapies. Incorporating cancer‐associated fibroblasts (CAFs) into organoid cultures improved patient therapy outcome prediction.
Marcin Grochowski, Liudmyla Dolinchuk, Michał Jerzak, Albert Gandurski, Tomasz Grochowski, Weronika Wojtyś, Maciej Zadrożny, Wojciech Kaźmierczak, Małgorzata Lenarcik, Marta Matejak‐Górska, Radosław Samsel, Tomasz Olesiński, Dawid Walerych   +12 more
wiley   +1 more source